BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23720457)

  • 1. Endothelin receptor antagonists attenuate the inflammatory response of human pulmonary vascular smooth muscle cells to bacterial endotoxin.
    Knobloch J; Feldmann M; Wahl C; Jungck D; Behr J; Stoelben E; Koch A
    J Pharmacol Exp Ther; 2013 Aug; 346(2):290-9. PubMed ID: 23720457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory responses of airway smooth muscle cells and effects of endothelin receptor antagonism.
    Knobloch J; Lin Y; Konradi J; Jungck D; Behr J; Strauch J; Stoelben E; Koch A
    Am J Respir Cell Mol Biol; 2013 Jul; 49(1):114-27. PubMed ID: 23590298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin receptor B protects granulocyte macrophage colony-stimulating factor mRNA from degradation.
    Jungck D; Knobloch J; Körber S; Lin Y; Konradi J; Yanik S; Stoelben E; Koch A
    J Pharmacol Exp Ther; 2015 Jun; 353(3):564-72. PubMed ID: 25855530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin receptor-antagonists suppress lipopolysaccharide-induced cytokine release from alveolar macrophages of non-smokers, smokers and COPD subjects.
    Gerlach K; Köhler-Bachmann S; Jungck D; Körber S; Yanik S; Knoop H; Wehde D; Rheinländer S; Walther JW; Kronsbein J; Knobloch J; Koch A
    Eur J Pharmacol; 2015 Dec; 768():123-30. PubMed ID: 26526351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNFα-induced airway smooth muscle cell proliferation depends on endothelin receptor signaling, GM-CSF and IL-6.
    Knobloch J; Yanik SD; Körber S; Stoelben E; Jungck D; Koch A
    Biochem Pharmacol; 2016 Sep; 116():188-99. PubMed ID: 27422754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow receptor dissociation kinetics differentiate macitentan from other endothelin receptor antagonists in pulmonary arterial smooth muscle cells.
    Gatfield J; Mueller Grandjean C; Sasse T; Clozel M; Nayler O
    PLoS One; 2012; 7(10):e47662. PubMed ID: 23077657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol attenuates the release of inflammatory cytokines from human bronchial smooth muscle cells exposed to lipoteichoic acid in chronic obstructive pulmonary disease.
    Knobloch J; Wahl C; Feldmann M; Jungck D; Strauch J; Stoelben E; Koch A
    Basic Clin Pharmacol Toxicol; 2014 Feb; 114(2):202-9. PubMed ID: 23981542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNFalpha-induced GM-CSF release from human airway smooth muscle cells depends on activation of an ET-1 autoregulatory positive feedback mechanism.
    Knobloch J; Peters H; Jungck D; Müller K; Strauch J; Koch A
    Thorax; 2009 Dec; 64(12):1044-52. PubMed ID: 19850966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in chronic obstructive pulmonary disease.
    Knobloch J; Sibbing B; Jungck D; Lin Y; Urban K; Stoelben E; Strauch J; Koch A
    J Pharmacol Exp Ther; 2010 Dec; 335(3):788-98. PubMed ID: 20801891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bosentan reverses the hypoxia-induced downregulation of the bone morphogenetic protein signaling in pulmonary artery smooth muscle cells.
    Maruyama H; Dewachter C; Sakai S; Belhaj A; Rondelet B; Remmelink M; Vachiéry JL; Naeije R; Dewachter L
    Life Sci; 2016 Aug; 159():111-115. PubMed ID: 27188586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of selective and unselective endothelin-receptor antagonists on prostacyclin synthase gene expression in experimental pulmonary hypertension.
    Schroll S; Arzt M; Sebah D; Stoelcker B; Luchner A; Budweiser S; Blumberg FC; Pfeifer M
    Scand J Clin Lab Invest; 2008; 68(4):270-6. PubMed ID: 18612919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional estimation of endothelin-1 receptor antagonism by bosentan, macitentan and ambrisentan in human pulmonary and radial arteries in vitro.
    Angus JA; Soeding PF; Hughes RJA; Wright CE
    Eur J Pharmacol; 2017 Jun; 804():111-116. PubMed ID: 28300593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin-1 induces pulmonary but not aortic smooth muscle cell migration by activating ERK1/2 MAP kinase.
    Meoli DF; White RJ
    Can J Physiol Pharmacol; 2010 Aug; 88(8):830-9. PubMed ID: 20725141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR4 mediates human retinal pigment epithelial endotoxin binding and cytokine expression.
    Elner SG; Petty HR; Elner VM; Yoshida A; Bian ZM; Yang D; Kindezelskii AL
    Trans Am Ophthalmol Soc; 2005; 103():126-35; discussion 135-7. PubMed ID: 17057796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced endothelin(A) receptor-mediated calcium mobilization and contraction in organ cultured porcine coronary arteries.
    Hill BJ; Katwa LC; Wamhoff BR; Sturek M
    J Pharmacol Exp Ther; 2000 Nov; 295(2):484-91. PubMed ID: 11046079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bosentan inhibits cigarette smoke-induced endothelin receptor expression in pulmonary arteries.
    Milara J; Gabarda E; Juan G; Ortiz JL; Guijarro R; Martorell M; Morcillo EJ; Cortijo J
    Eur Respir J; 2012 Apr; 39(4):927-38. PubMed ID: 21828025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LBP and CD14 secreted in tears by the lacrimal glands modulate the LPS response of corneal epithelial cells.
    Blais DR; Vascotto SG; Griffith M; Altosaar I
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4235-44. PubMed ID: 16249503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha1-Antitrypsin regulates CD14 expression and soluble CD14 levels in human monocytes in vitro.
    Nita IM; Serapinas D; Janciauskiene SM
    Int J Biochem Cell Biol; 2007; 39(6):1165-76. PubMed ID: 17448722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages in chronic obstructive pulmonary disease.
    Knobloch J; Hag H; Jungck D; Urban K; Koch A
    Basic Clin Pharmacol Toxicol; 2011 Aug; 109(2):138-43. PubMed ID: 21447053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1beta, transforming growth factor-beta1, and bradykinin attenuate cyclic AMP production by human pulmonary artery smooth muscle cells in response to prostacyclin analogues and prostaglandin E2 by cyclooxygenase-2 induction and downregulation of adenylyl cyclase isoforms 1, 2, and 4.
    El-Haroun H; Bradbury D; Clayton A; Knox AJ
    Circ Res; 2004 Feb; 94(3):353-61. PubMed ID: 14670842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.